Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction: development and internal validatio
Not Applicable
Completed
- Conditions
- Contrast-induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score,contrast-induced nephropathy,STEMI
- Registration Number
- TCTR20190705001
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 217
Inclusion Criteria
Acute ST segment elevated myocardial infarction patients aged more than 18 years old who were treated with primary percutaneous coronary intervention at cardiac catheterization laboratory of the institute were included from June 1, 2017 to June 30, 2018. End-stage renal disease patients with estimated glomerular filtration less than 15 ml/min/1.73 m2 or being treated with peritoneal or hemodialysis.
Exclusion Criteria
Patients who were exposed to contrast media agent 7 days prior to the index PCI procedure, and patients who did not survive primary PCI were excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Contrast-induced nephropathy At 48 hours after primary PCI Incidence
- Secondary Outcome Measures
Name Time Method /A N/A N/A